High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$600M
$600,050,778
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ROIV |
Roivant Sciences Ltd.
|
President
10b5-1 Sell
|
2026-02-23 | $16,159,099MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
10b5-1 Sell
|
2026-02-20 | $27,492,362MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
10b5-1 Sell
|
2026-02-19 | $38,388,000MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2026-02-13
$9,956,768Whalex2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-13 | $9,956,768Whalex2 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2026-02-13
$9,956,768Whalex2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-13 | $9,956,768Whalex2 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
QVT Financial LP
• Other
Discretionary Sell
2026-02-13
$9,956,768Whalex2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2026-02-13 | $9,956,768Whalex2 | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -10.8%
|
2026-02-13 | $5,298,000Whale | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2026-02-12
$11,367,000MEGAx2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-12 | $11,367,000MEGAx2 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2026-02-12
$11,367,000MEGAx2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-12 | $11,367,000MEGAx2 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
QVT Financial LP
• Other
Discretionary Sell
2026-02-12
$11,367,000MEGAx2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2026-02-12 | $11,367,000MEGAx2 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2026-02-11
$11,334,750MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-11 | $11,334,750MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2026-02-11
$11,334,750MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2026-02-11 | $11,334,750MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2026-02-11 | $11,334,750MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Sukhatme Mayukh
• President
Discretionary Sell
2026-02-09
$8,985,003Whale
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
President
Discretionary Sell
|
2026-02-09 | $8,985,003Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -10.8%
|
2026-01-12 | $4,384,000Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2025-12-17
$17,935,595MEGAx3
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-12-17 | $17,935,595MEGAx3 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2025-12-17
$17,935,595MEGAx3
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-12-17 | $17,935,595MEGAx3 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
QVT Financial LP
• Other
Discretionary Sell
2025-12-17
$17,935,595MEGAx3
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2025-12-17 | $17,935,595MEGAx3 | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
President
Discretionary Sell
|
2025-12-17 | $619,528 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2025-12-16
$21,129,619MEGAx2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-12-16 | $21,129,619MEGAx2 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2025-12-16
$21,129,619MEGAx2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-12-16 | $21,129,619MEGAx2 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
QVT Financial LP
• Other
Discretionary Sell
2025-12-16
$21,129,619MEGAx2
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2025-12-16 | $21,129,619MEGAx2 | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
Discretionary Sell
|
2025-12-15 | $37,723,200MEGAx3 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Ramaswamy Vivek
• 10% Owner
Discretionary Sell
2025-12-15
$7,800,077Whale
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Discretionary Sell
|
2025-12-15 | $7,800,077Whale | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Ramaswamy Vivek
• 10% Owner
Discretionary Sell
2025-12-12
$43,389,842MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Discretionary Sell
|
2025-12-12 | $43,389,842MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Ramaswamy Vivek
• 10% Owner
Discretionary Sell
2025-12-11
$16,752,433MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Discretionary Sell
|
2025-12-11 | $16,752,433MEGA | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -11.8%
|
2025-12-09 | $4,170,000Large | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Gold Daniel Allen
• Director
Discretionary Sell
2025-11-19
$26,304,500MEGAx4
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-11-19 | $26,304,500MEGAx4 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
MANCHESTER KEITH S
• Director
Discretionary Sell
2025-11-19
$26,304,500MEGAx4
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Director
Discretionary Sell
|
2025-11-19 | $26,304,500MEGAx4 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
QVT Financial LP
• Other
Discretionary Sell
2025-11-19
$26,304,500MEGAx4
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
Other
Discretionary Sell
|
2025-11-19 | $26,304,500MEGAx4 | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Ramaswamy Vivek
• 10% Owner
Discretionary Sell
2025-11-17
$11,068,222MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Discretionary Sell
|
2025-11-17 | $11,068,222MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Ramaswamy Vivek
• 10% Owner
Discretionary Sell
2025-11-14
$20,892,531MEGA
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Discretionary Sell
|
2025-11-14 | $20,892,531MEGA | S | Form 4 |
|
ROIV
S
Roivant Sciences Ltd.
Ramaswamy Vivek
• 10% Owner
Discretionary Sell
2025-11-13
$5,978,359Whale
|
||||||
| ROIV |
Roivant Sciences Ltd.
|
10% Owner
Discretionary Sell
|
2025-11-13 | $5,978,359Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -11.7%
|
2025-11-07 | $4,044,000Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-10-17 | $2,020,211Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -17.5%
|
2025-10-16 | $5,426,708Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -21.6%
|
2025-10-15 | $7,020,583Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-10-13 | $336,814 | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-10-09 | $1,710,522Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-10-08 | $2,245,352Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -19.1%
|
2025-10-07 | $5,735,850Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -10.2%
|
2025-10-06 | $2,800,611Large | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -28.9%
|
2025-09-23 | $9,061,130Whale | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 Sell
|
2025-09-22 | $6,240,568Whalex2 | S | Form 4 |
| ROIV |
Roivant Sciences Ltd.
|
CEO
10b5-1 SellΔOwn -25.8%
|
2025-09-19 | $10,223,079MEGA | S | Form 4 |